Quipt Home Medical (QIPT) | Financial Analysis & Statements
Quipt Home Medical Corp. Micro-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Sep 2025Income Metrics
Revenue
68.3M
Gross Profit
47.9M
70.13%
Operating Income
-621.0K
-0.91%
Net Income
-3.4M
-5.02%
Balance Sheet Metrics
Total Assets
283.3M
Total Liabilities
171.2M
Shareholders Equity
112.1M
Debt to Equity
1.53
Cash Flow Metrics
Operating Cash Flow
6.8M
Free Cash Flow
8.0M
Revenue & Profitability Trend
Quarter Income Flow
Sep 30, 2025
Annual Income Flow
2025
Quipt Home Medical Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 245.4M | 245.9M | 211.7M | 139.9M | 102.4M |
| Cost of Goods Sold | 68.2M | 68.9M | 57.9M | 33.2M | 28.2M |
| Gross Profit | 177.2M | 177.0M | 153.8M | 106.6M | 74.2M |
| Gross Margin % | 72.2% | 72.0% | 72.6% | 76.3% | 72.5% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 97.5M | 94.7M | 82.4M | 53.8M | 39.4M |
| Other Operating Expenses | 29.7M | 28.2M | 24.4M | 15.9M | 10.3M |
| Total Operating Expenses | 127.2M | 122.9M | 106.8M | 69.7M | 49.8M |
| Operating Income | -1.9M | 3.5M | 10.9M | 13.9M | 6.6M |
| Operating Margin % | -0.8% | 1.4% | 5.2% | 9.9% | 6.5% |
| Non-Operating Items | |||||
| Interest Income | 467.0K | 787.0K | 369.0K | - | - |
| Interest Expense | 6.7M | 7.2M | 11.0M | 2.1M | 2.0M |
| Other Non-Operating Income | 169.0K | -1.7M | -1.2M | -7.9M | -14.0M |
| Pre-tax Income | -10.3M | -6.7M | -2.7M | 2.9M | -9.3M |
| Income Tax | 241.0K | 109.0K | 85.0K | -1.9M | -3.2M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | -64.9% | 0.0% |
| Net Income | -10.6M | -6.8M | -2.8M | 4.8M | -6.2M |
| Net Margin % | -4.3% | -2.8% | -1.3% | 3.5% | -6.0% |
| Key Metrics | |||||
| EBITDA | 47.8M | 52.4M | 50.7M | 36.7M | 20.8M |
| EPS (Basic) | $-0.24 | $-0.16 | $-0.07 | $0.14 | $-0.20 |
| EPS (Diluted) | $-0.24 | $-0.16 | $-0.07 | $0.13 | $-0.20 |
| Basic Shares Outstanding | 43291000 | 42501000 | 38607000 | 34564286 | 30438000 |
| Diluted Shares Outstanding | 43291000 | 42501000 | 38607000 | 34564286 | 30438000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Quipt Home Medical Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 12.9M | 16.2M | 17.2M | 8.5M | 34.6M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 34.7M | 29.1M | 26.0M | 16.4M | 11.9M |
| Inventory | 25.6M | 20.9M | 18.4M | 15.6M | 9.3M |
| Other Current Assets | 984.0K | 926.0K | 372.0K | 1.1M | - |
| Total Current Assets | 78.3M | 73.1M | 65.4M | 41.5M | 57.2M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 77.8M | 64.6M | 61.7M | 36.9M | 31.1M |
| Goodwill | 200.7M | 169.4M | 179.7M | 85.3M | 39.8M |
| Intangible Assets | 77.6M | 68.0M | 74.0M | 28.9M | 14.9M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 384.0K | 337.0K | 294.0K | 85.0K | 920.0K |
| Total Non-Current Assets | 204.9M | 174.2M | 182.0M | 90.7M | 51.3M |
| Total Assets | 283.3M | 247.2M | 247.4M | 132.2M | 108.6M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 38.4M | 29.3M | 24.7M | 13.8M | 9.8M |
| Short-term Debt | 23.3M | 21.9M | 22.6M | 15.6M | 10.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 74.7M | 60.8M | 60.6M | 41.7M | 32.7M |
| Non-Current Liabilities | |||||
| Long-term Debt | 95.5M | 77.9M | 75.4M | 10.9M | 17.1M |
| Deferred Tax Liabilities | 287.0K | 202.0K | 344.0K | 0 | - |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 96.5M | 79.2M | 75.7M | 10.9M | 17.2M |
| Total Liabilities | 171.2M | 140.1M | 136.3M | 52.7M | 50.0M |
| Equity | |||||
| Common Stock | 0 | 0 | 0 | 214.3M | 202.8M |
| Retained Earnings | -181.3M | -170.6M | -163.8M | -161.0M | -165.9M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 112.1M | 107.2M | 111.1M | 79.5M | 58.6M |
| Key Metrics | |||||
| Total Debt | 118.8M | 99.8M | 98.0M | 26.6M | 27.1M |
| Working Capital | 3.6M | 12.2M | 4.9M | -204.0K | 24.5M |
Balance Sheet Composition
Quipt Home Medical Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -10.7M | -6.8M | -2.8M | 4.8M | -6.2M |
| Depreciation & Amortization | 51.9M | 50.6M | 41.2M | 23.0M | 17.8M |
| Stock-Based Compensation | 4.0M | 2.5M | 5.3M | 5.5M | 5.0M |
| Working Capital Changes | -3.3M | -4.5M | 233.0K | -2.6M | -107.0K |
| Operating Cash Flow | 36.5M | 37.2M | 39.3M | 25.2M | 18.9M |
| Investing Activities | |||||
| Capital Expenditures | -11.1M | -10.1M | -6.8M | -9.0M | -4.9M |
| Acquisitions | -21.8M | -210.0K | -76.0M | -33.5M | -12.9M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -32.9M | -10.3M | -82.8M | -42.5M | -17.8M |
| Financing Activities | |||||
| Share Repurchases | -130.0K | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 35.6M | 0 | 64.0M | 0 | 0 |
| Debt Repayment | -43.2M | -42.6M | -47.4M | -15.7M | -13.0M |
| Financing Cash Flow | -7.8M | -26.7M | 53.9M | -10.4M | -14.2M |
| Free Cash Flow | 25.3M | 25.1M | 30.1M | 17.2M | 12.7M |
| Net Change in Cash | -4.2M | 196.0K | 10.4M | -27.7M | -13.2M |
Cash Flow Trend
Quipt Home Medical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
493.00
Forward P/E
182.50
Price to Book
1.59
Price to Sales
0.61
PEG Ratio
-14.79
Profitability Ratios
Profit Margin
-4.03%
Operating Margin
1.54%
Return on Equity
-9.31%
Return on Assets
-0.83%
Financial Health
Current Ratio
1.04
Debt to Equity
102.33
Beta
0.50
Per Share Data
EPS (TTM)
$-0.23
Book Value per Share
$2.29
Revenue per Share
$6.10
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| QIPT | 162.3M | 493.00 | 1.59 | -9.31% | -4.03% | 102.33 |
| McKesson | 103.2B | 24.33 | -1,040.14 | -194.51% | 1.09% | -88.23 |
| Cencora | 60.6B | 37.46 | 31.84 | 133.47% | 0.50% | 472.58 |
| Owens & Minor | 184.1M | - | - | -196.39% | -12.45% | -4.86 |
| Synergy CHC | 5.2M | 3.86 | - | 53.36% | -40.62% | -1.16 |
| Cosmos Health | 18.1M | - | 0.78 | -89.13% | -29.33% | 108.39 |
Financial data is updated regularly. All figures are in the company's reporting currency.





